T cell activation profiles in Kawasaki syndrome

Clinical and Experimental Immunology

Volumn 151, Issue 2, 2008, Pages 267-274

  Brogan, P A ^a   Shah, V ^a   Clarke, L A ^a   Dillon, M J ^a   Klein, N ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Child; Kawasaki syndrome; Superantigen; T cells; Vasculitis

Indexed keywords

CD4 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE ACTIVATION; TECHNIQUE;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LYMPHOCYTE ACTIVATION; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SUPERANTIGENS; T-LYMPHOCYTE SUBSETS;

EID: 37849053938     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03567.x     Document Type: Article

References (36)

1. Brogan PA, Bose A, Burgner D et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child 2002 86 : 286 90.
2. Newburger JW, Takahashi M, Gerber MA et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004 110 : 2747 71.
3. Brogan PA, Shah V, Bagga A, Klein N, Dillon MJ. T cell Vbeta repertoires in childhood vasculitides. Clin Exp Immunol 2003 131 : 517 27.
4. Cohen Tervaert JW, Popa ER, Bos NA. The role of superantigens in vasculitis. Curr Opin Rheumatol 1999 11 : 24 33.
5. Barron KS. Kawasaki disease: etiology, pathogenesis, and treatment. Cleve Clin J Med 2002 69 (Suppl. 2 SII69 78.
6. Rowley AH, Shulman ST. New developments in the search for the etiologic agent of Kawasaki disease. Curr Opin Pediatr 2007 19 : 71 4.
7. Brogan PA, Shah V, Klein N, Dillon MJ. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury. Arthritis Rheum 2004 50 : 589 97.
8. Li H, Llera A, Malchiodi EL, Mariuzza RA. The structural basis of T cell activation by superantigens. Annu Rev Immunol 1999 17 : 435 66.
9. Abe J, Kotzin BL, Jujo K et al. Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci USA 1992 89 : 4066 70.
10. Curtis N, Zheng R, Lamb JR, Levin M. Evidence for a superantigen mediated process in Kawasaki disease. Arch Dis Child 1995 72 : 308 11.
11. Curtis N. Kawasaki disease and toxic shock syndrome - at last the etiology is clear? Adv Exp Med 2004 549 : 191 200.
12. Leung DYM, Meissner HC, Fulton DR, Abe J, Quimby F, Schlievert PM. Superantigen hypothesis of Kawasaki syndrome. In : Kato H, ed. Kawasaki Disease. Amsterdam : Elsevier, 1995 : 120 126.
13. Leung DYM, Giorno RC, Kazemi LV, Flynn PA, Busse JB. Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome. J Immunol 1995 155 : 5018 21.
14. Abe J, Kotzin BL, Meissner C et al. Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med 1993 177 : 791 6.
15. Reichardt P, Lehmann I, Sierig G, Borte M. Analysis of T-cell receptor V-beta 2 in peripheral blood lymphocytes as a diagnostic marker for Kawasaki disease. Infection 2002 30 : 360 4.
16. Nomura Y, Masuda K, Shinkoda Y et al. Twenty-five types of T-cell receptor Vbeta family repertoire in patients with Kawasaki syndrome. Eur J Pediatr 1998 157 : 981 6.
17. Leung DY, Meissner HC, Shulman ST et al. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J Pediatr 2002 140 : 742 6.
18. Matsubara K, Fukaya T, Miwa K et al. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease. Clin Exp Immunol 2006 143 : 427 34.
19. Yamashiro Y, Nagata S, Oguchi S, Shimizu T. Selective increase of V beta 2+ T cells in the small intestinal mucosa in Kawasaki disease. Pediatr Res 1996 39 : 264 6.
20. Terai M, Kohno Y, Namba M et al. Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease. Hum Pathol 1990 21 : 231 4.
21. Mancia L, Wahlstrom J, Schiller B et al. Characterization of the T-cell receptor V-beta repertoire in Kawasaki disease. Scand J Immunol 1998 48 : 443 9.
22. Nishiyori A, Sakaguchi M, Kato H et al. Toxic shock syndrome toxin-1 and Vb 2 expression on T cells in Kawasaki disease. In : Kato H, ed. Kawasaki Disease. Amsterdam : Elsevier, 1995 : 139 43.
23. Pietra BA, De Inocencio J, Giannini EH, Hirsch R. TCR V beta family repertoire and T cell activation markers in Kawasaki disease. J Immunol 1994 153 : 1881 8.
24. + T helper cells. Clin Exp Immunol 1995 99 : 276 82.
25. Rowley AH, Shulman ST, Spike BT, Mask CA, Baker SC. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J Immunol 2001 166 : 1334 43.
26. Shoukry NH, Lavoie PM, Thibodeau J, D'Souza S, Sekaly RP. MHC class II-dependent peptide antigen versus superantigen presentation to T cells. Hum Immunol 1997 54 : 194 201.
27. Islam D, Wretlind B, Lindberg AA, Christensson B. Changes in the peripheral blood T-Cell receptor V beta repertoire in vivo and in vitro during shigellosis. Infect Immun 1996 64 : 1391 9.
28. Varela-Calvino R, Sgarbi G, Wedderburn LR, Dayan CM, Tremble J, Peakman M. T cell activation by coxsackievirus B4 antigens in type 1 diabetes mellitus: evidence for selective TCR Vbeta usage without superantigenic activity. J Immunol 2001 167 : 3513 20.
29. Furukawa S, Matsubara T, Tsuji K, Motohashi T, Okumura K, Yabuta K. Serum soluble CD4 and CD8 levels in Kawasaki disease. Clin Exp Immunol 1991 86 : 134 9.
30. Furukawa S, Matsubara T, Tsuji K, Okumura K, Yabuta K. Transient depletion of T cells with bright CD11a/CD18 expression from peripheral circulation during acute Kawasaki disease. Scand J Immunol 1993 37 : 377 80.
31. Matsubara T, Ichiyama T, Furukawa S. Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease. Clin Exp Immunol 2005 141 : 381 7.
32. Terai M, Kohno Y, Niwa K, Toba T, Sakurai N, Nakajima H. Imbalance among T-cell subsets in patients with coronary arterial aneurysms in Kawasaki disease. Am J Cardiol 1987 60 : 555 9.
33. Leung DY, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993 342 : 1385 8.
34. Orwin PM, Leung DY, Tripp TJ et al. Characterization of a novel staphylococcal enterotoxin-like superantigen, a member of the group V subfamily of pyrogenic toxins. Biochemistry 2002 41 : 14033 40.
35. Watanabe-Ohnishi R, Low DE, McGeer A et al. Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project. J Infect Dis 1995 171 : 74 84.
36. Benseler SM, McCrindle BW, Silverman ED, Tyrrell PN, Wong J, Yeung RS. Infections and Kawasaki disease: implications for coronary artery outcome. Pediatrics 2005 116 : e760 6.